Compare INFU & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFU | CDLX |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.6M | 114.5M |
| IPO Year | N/A | 2018 |
| Metric | INFU | CDLX |
|---|---|---|
| Price | $9.24 | $1.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $14.50 | $2.25 |
| AVG Volume (30 Days) | 120.9K | ★ 767.0K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 271.43 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | $141,054,000.00 | ★ $251,175,000.00 |
| Revenue This Year | $8.84 | N/A |
| Revenue Next Year | $3.67 | N/A |
| P/E Ratio | $35.63 | ★ N/A |
| Revenue Growth | ★ 6.23 | N/A |
| 52 Week Low | $4.61 | $0.85 |
| 52 Week High | $11.04 | $4.05 |
| Indicator | INFU | CDLX |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 37.29 |
| Support Level | $8.67 | $1.03 |
| Resistance Level | $9.38 | $1.23 |
| Average True Range (ATR) | 0.36 | 0.11 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 56.41 | 21.74 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.